| |
| Device | NATRELLE Silicon-Filled Breast Implants |
| Generic Name | Prosthesis, breast, noninflatable, internal, silicone gel-filled |
| Regulation Number | 878.3540 |
| Applicant | Allergan 2525 Dupont Dr. Irvine, CA 92612 |
| PMA Number | P020056 |
| Supplement Number | S040 |
| Date Received | 03/01/2017 |
| Decision Date | 08/28/2017 |
| Product Code |
FTR |
| Advisory Committee |
General & Plastic Surgery |
| Supplement Type | Normal 180 Day Track |
| Supplement Reason | Labeling Change - Indications/instructions/shelf life/tradename |
| Expedited Review Granted? | No |
| Combination Product | No |
| Predetermined Change Control Plan Authorized | No |
| Recalls | CDRH Recalls |
Approval Order Statement Approval for changes to the labeling including 1) the removal of the Betadine warning against breast implant exposure to Betadine brand povidone-iodine 10% (applicable to generic versions as well) from the patient and physician labeling; and 2) modifications to the language in the physician and patient labeling regarding the potential risk of breast implant associated anaplastic large cell lymphoma (BIA-ALCL). |
| Post-Approval Study | Show Report Schedule and Study Progress |